CTLA4-Ig inhibits allergic airway inflammation by a novel CD28-independent, nitric oxide synthase-dependent mechanism

European Journal of Immunology

Volumn 40, Issue 7, 2010, Pages 1985-1994

  Deppong, Christine M ^a   Parulekar, Amit ^a   Boomer, Jonathan S ^a   Bricker, Traci L ^a   Green, Jonathan M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allergic lung inflammation; Costimulation; CTLA4 Ig; T cell activation

Indexed keywords

B LYMPHOCYTE ANTIBODY; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; ABATACEPT; ANTIBODY CONJUGATE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOSUPPRESSIVE AGENT;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; GENOTYPE; HISTOPATHOLOGY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; ANIMAL; ASTHMA; C57BL MOUSE; DRUG EFFECTS; HYPERSENSITIVITY; IMMUNOLOGY; INFLAMMATION; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY SYSTEM; T LYMPHOCYTE;

ABATACEPT; ANIMALS; ANTIGENS, CD28; ASTHMA; CTLA-4 ANTIGEN; HYPERSENSITIVITY; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY SYSTEM; T-LYMPHOCYTES;

EID: 77954122076     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200940282     Document Type: Article

References (54)

1. Carreno, B. M. and Collins, M., The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 2002. 20: 29-53.
2. Keir, M. E. and Sharpe, A. H., The B7/CD28 costimulatory family in autoimmunity. Immunol. Rev. 2005. 204: 128-143.
3. Lesslauer, W., Koning, F., Ottenhoff, T., Giphart, M., Goulmy, E. and van Rood, J. J., T90/44 (9.3 antigen). A cell surface molecule with a function in human T cell activation. Eur. J. Immunol. 1986. 16: 1289-1296.
4. Pierres, A., Lopez, M., Cerdan, C., Nunes, J., Olive, D. and Mawas, C., Triggering CD 28 molecules synergize with CD 2 (T 11.1 and T 11.2)-mediated T cell activation. Eur. J. Immunol. 1988. 18: 685-690.
5. Damle, N. K., Doyle, L. V., Grosmaire, L. S. and Ledbetter, J. A., Differential regulatory signals delivered by antibody binding to the CD28 (Tp44) molecule during the activation of human T lymphocytes. J. Immunol. 1988. 140: 1753-1761.
6. Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I. and Kroczek, R. A., ICOS is an inducible T-cell costimulator structurally and functionally related to CD28. Nature 1999. 397: 263-266. (Pubitemid 129601065)
7. Toennies, H. M., Green, J. M. and Arch, R. H., Expression of CD30 and Ox40 on T lymphocyte subsets is controlled by distinct regulatory mechanisms. J. Leukoc. Biol. 2004. 75: 350-357.
8. Brunet, J. F., Denizot, F., Luciani, M. F., Roux-Dosseto, M., Suzan, M., Mattei, M. G. and Golstein, P., A new member of the immunoglobulin superfamily - CTLA-4. Nature 1987. 328: 267-270.
9. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B. and Bluestone, J. A., CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994. 1: 405-413.
10. Watanabe, N., Gavrieli, M., Sedy, J. R., Yang, J., Fallarino, F., Loftin, S. K., Hurchla, M. A. et al., BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 2003. 4: 670-679.
11. Deppong, C., Juehne, T. I., Hurchla, M., Friend, L. D., Shah, D. D., Rose, C. M., Bricker, T. L. et al., Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation. J. Immunol. 2006. 176: 3909-3913.
12. Burr, J. S., Kimzey, S. L., Randolph, D. R. and Green, J. M., CD28 and CTLA4 coordinately regulate airway inflammatory cell recruitment and T-helper cell differentiation after inhaled allergen. Am. J. Respir. Cell. Mol. Biol. 2001. 24: 563-568.
13. Kimzey, S. L., Liu, P. and Green, J. M., Requirement for CD28 in the effector phase of allergic airway inflammation. J. Immunol. 2004. 173: 632-640. (Pubitemid 38797393)
14. Harris, N., Campbell, C., Le Gros, G. and Ronchese, F., Blockade of CD28/ B7 co-stimulation by mCTLA4-Hγ1 inhibits antigen-induced lung eosinophilia but not Th2 cell development or recruitment in the lung. Eur. J. Immunol. 1997. 27: 155-161.
15. Keane-Myers, A., Gause, W. C., Linsley, P. S., Chen, S. J. and Wills-Karp, M., B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J. Immunol. 1997. 158: 2042-2049.
16. Linsley, P. S., Wallace, P. M., Johnson, J., Gibson, M. G., Greene, J. L., Ledbetter, J. A., Singh, C. and Tepper, M. A., Immunosuppression in vivo by the soluble form of the CTLA-4 T cell activation molecule. Science 1992. 257: 792-795.
17. Linsley, P. S. and Nadler, S. G., The clinical utility of inhibiting CD28-mediated costimulation. Immunol. Rev. 2009. 229: 307-321.
18. Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P. et al., CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 2002. 3: 1097-1101.
19. Boasso, A., Herbeuval, J. P., Hardy, A. W., Winkler, C. and Shearer, G. M., Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells. Blood 2005. 105: 1574-1581.
20. Kung, T. T., Jones, H., Adams, G. K., III, Umland, S. P., Kreutner,W., Egan, R. W., Chapman, R. W. and Watnick, A. S., Characterization of a murine model of allergic pulmonary inflammation. Int. Arch. Allergy Immunol. 1994. 105: 83-90.
21. Deppong, C., Degnan, J. M., Murphy, T. L., Murphy, K. M. and Green, J. M., B and T lymphocyte attenuator regulates T cell survival in the lung. J. Immunol. 2008. 181: 2973-2979.
22. Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S. and Bluestone, J. A., Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 1992. 257: 789-792.
23. Turka, L. A., Linsley, P. S., Lin, H., Brady, W., Leiden, J. M., Wei, R.-Q., Gibson, M. L. et al., T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA 1992. 89: 11102-11105.
24. Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B. et al., Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 2002. 297: 1867-1870.
25. Mellor, A. L., Baban, B., Chandler, P., Marshall, B., Jhaver, K., Hansen, A., Koni, P. A. et al., Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J. Immunol. 2003. 171: 1652-1655.
26. Mellor, A. L., Chandler, P., Baban, B., Hansen, A. M., Marshall, B., Pihkala, J., Waldmann, H. et al., Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase. Int. Immunol. 2004. 16: 1391-1401.
27. Munn, D. H., Sharma, M. D., Baban, B., Harding, H. P., Zhang, Y., Ron, D. and Mellor, A. L., GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 2005. 22: 633-642.
28. Gurtner, G. J., Newberry, R. D., Schloemann, S. R., McDonald, K. G. and Stenson, W. F., Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. Gastroenterology 2003. 125: 1762-1773.
29. Bronte, V. and Zanovello, P., Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 2005. 5: 641-654.
30. Finck, B. K., Linsley, P. S. and Wofsy, D., Treatment of murine lupus with CTLA4Ig. Science 1994. 265: 1225-1227.
31. Khoury, S. J., Akalin, E., Chandraker, A., Turka, L. A., Linsley, P. S., Sayegh, M. H. and Hancock, W. W., CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J. Immunol. 1995. 155: 4521-4524.
32. Harris, N., Peach, R., Naemura, J., Linsley, P. S., Le Gros, G. and Ronchese, F., CD80 costimulation is essential for the induction of airway eosinophilia. J. Exp. Med. 1997. 185: 177-182.
33. Van Oosterhout, A. J., Hofstra, C. L., Shields, R., Chan, B., Van Ark, I., Jardieu, P. M. and Nijkamp, F. P., Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma. Am. J. Respir. Cell. Mol. Biol. 1997. 17: 386-392.
34. Genovese, M. C., Becker, J. C., Schiff, M., Luggen, M., Sherrer, Y., Kremer, J., Birbara, C. et al., Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. N. Engl. J. Med. 2005. 353: 1114-1123.
35. Sharma, M. D., Baban, B., Chandler, P., Hou, D. Y., Singh, N., Yagita, H., Azuma, M. et al., Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J. Clin. Invest. 2007. 117: 2570-2582.
36. Chen, W., Liang, X., Peterson, A. J., Munn, D. H. and Blazar, B. R., The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J. Immunol. 2008. 181: 5396-5404.
37. Bahri, R., Naji, A., Menier, C., Charpentier, B., Carosella, E. D., Rouas-Freiss, N. and Durrbach, A., Dendritic cells secrete the immunosuppressive HLA-G molecule upon CTLA4-Ig treatment: implication in human renal transplant acceptance. J. Immunol. 2009. 183: 7054-7062.
38. Liang, S., Ristich, V., Arase, H., Dausset, J., Carosella, E. D. and Horuzsko, A., Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6 - STAT3 signaling pathway. Proc. Natl. Acad. Sci. 2008. 105: 8357-8362.
39. Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J. H., Apolloni, E., Serafini, P., Zanovello, P. and Segal, D. M., Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J. Immunol. 2002. 168: 689-695. (Pubitemid 34049569)
40. Bingisser, R. M., Tilbrook, P. A., Holt, P. G. and Kees, U. R., Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J. Immunol. 1998. 160: 5729-5734.
41. Duhe, R. J., Evans, G. A., Erwin, R. A., Kirken, R. A., Cox, G.W. and Farrar, W. L., Nitric oxide and thiol redox regulation of Janus kinase activity. Proc. Natl. Acad. Sci. USA 1998. 95: 126-131.
42. Currie, G. A., Gyure, L. and Cifuentes, L., Microenvironmental arginine depletion by macrophages in vivo. Br. J. Cancer 1979. 39: 613-620. (Pubitemid 9200725)
43. Zhang, P., McGrath, B. C., Reinert, J., Olsen, D. S., Lei, L., Gill, S., Wek, S. A. et al., The GCN2 eIF2alpha kinase is required for adaptation to amino acid deprivation in mice. Mol. Cell. Biol. 2002. 22: 6681-6688.
44. Hill, M., Zagani, R., Voisine, C., Usal, C. and Anegon, I., Nitric oxide and indoleamine 2,3-dioxygenase mediate CTLA4Ig-induced survival in heart allografts in rats. Transplantation 2007. 84: 1060-1063.
45. Xiong, Y., Karupiah, G., Hogan, S. P., Foster, P. S. and Ramsay, A. J., Inhibition of allergic airway inflammation in mice lacking nitric oxide synthase 2. J. Immunol. 1999. 162: 445-452. (Pubitemid 29018952)
46. Trifilieff, A., Fujitani, Y., Mentz, F., Dugas, B., Fuentes, M. and Bertrand, C., Inducible nitric oxide synthase inhibitors suppress airway inflammation in mice through down-regulation of chemokine expression. J. Immunol. 2000. 165: 1526-1533. (Pubitemid 30604588)
47. De Sanctis, G. T., MacLean, J. A., Hamada, K., Mehta, S., Scott, J. A., Jiao, A., Yandava, C. N. et al., Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J. Exp. Med. 1999. 189: 1621-1630.
48. Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A., Kawai, K. et al., Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993. 261: 609-612.
49. Hurchla, M. A., Sedy, J. R., Gavrieli, M., Drake, C. G., Murphy, T. L. and Murphy, K. M., B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4+ T cells. J. Immunol. 2005. 174: 3377-3385.
50. Woerly, G., Roger, N., Loiseau, S., Dombrowicz, D., Capron, A. and Capron, M., Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin a complexes. J. Exp. Med. 1999. 190: 487-495.
51. Woerly, G., Lacy, P., Younes, A. B., Roger, N., Loiseau, S., Moqbel, R. and Capron, M., Human eosinophils express and release IL-13 following CD28-dependent activation. J. Leukoc. Biol. 2002. 72: 769-779.
52. Venuprasad, K., Chattopadhyay, S. and Saha, B., CD28 signaling in neutrophil induces T-cell chemotactic factor(s) modulating T-cell response. Hum. Immunol. 2003. 64: 38-43.
53. Venuprasad, K., Parab, P., Prasad, D. V., Sharma, S., Banerjee, P. R., Deshpande, M., Mitra, D. K. et al., Immunobiology of CD28 expression on human neutrophils. I. CD28 regulates neutrophil migration by modulating CXCR-1 expression. Eur. J. Immunol. 2001. 31: 1536-1543.
54. Lee, K. P., Taylor, C., Petryniak, B., Turka, L. A., June, C. H. and Thompson, C. B., The genomic organization of the CD28 gene. Implications for the regulation of CD28 mRNA expression and heterogeneity. J. Immunol. 1990. 145: 344-352.